Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-05-03

AUTHORS

A Nazha, R Cook, D T Vogl, P A Mangan, M Gardler, K Hummel, K Cunningham, S M Luger, D L Porter, S Schuster, U O'Doherty, D Siegel, E A Stadtmauer

ABSTRACT

Lenalidomide is an active treatment for multiple myeloma (MM) and is increasingly used as part of the initial treatment of this disease. Recent reports have suggested decreases in the number of CD34+ cells collected and increases in the failure rate among patients whose initial therapy contained lenalidomide when mobilized with G-CSF alone. A retrospective data analysis of 364 patients with MM who underwent stem cell mobilization and attempted harvest at the Hospital of the University of Pennsylvania between January 2002 and December 2007 was performed. Forty-three of the patients received lenalidomide in their induction regimen, and were mobilized with either CY and G-CSF or G-CSF alone. The number of apheresis cycles and the failure rate were lower, whereas the mean number of collected stem cells was higher in patients who were mobilized with CY and G-CSF in comparison with G-CSF alone. This suggests that lenalidomide does not prevent the harvest of adequate numbers of CD34 cells for autologous stem cell transplant, but mobilization with G-CSF and CY may be required to obtain adequate numbers of stem cells. Finally, in our study, the number of lenalidomide cycles did not correlate with stem cell yield. More... »

PAGES

59-63

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2010.63

DOI

http://dx.doi.org/10.1038/bmt.2010.63

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041512897

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20421869


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD34", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Component Removal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Granulocyte Colony-Stimulating Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Mobilization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lenalidomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Records", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Blood Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thalidomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nazha", 
        "givenName": "A", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cook", 
        "givenName": "R", 
        "id": "sg:person.01175252676.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175252676.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vogl", 
        "givenName": "D T", 
        "id": "sg:person.01154427341.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154427341.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mangan", 
        "givenName": "P A", 
        "id": "sg:person.01342007330.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342007330.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gardler", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hummel", 
        "givenName": "K", 
        "id": "sg:person.0726540325.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726540325.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cunningham", 
        "givenName": "K", 
        "id": "sg:person.0634210376.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634210376.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luger", 
        "givenName": "S M", 
        "id": "sg:person.012415664717.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012415664717.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porter", 
        "givenName": "D L", 
        "id": "sg:person.0707416147.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schuster", 
        "givenName": "S", 
        "id": "sg:person.011060364477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O'Doherty", 
        "givenName": "U", 
        "id": "sg:person.0626647504.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626647504.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Siegel", 
        "givenName": "D", 
        "id": "sg:person.014314214442.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014314214442.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stadtmauer", 
        "givenName": "E A", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.leu.2405035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027346890", 
          "https://doi.org/10.1038/sj.leu.2405035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011029060", 
          "https://doi.org/10.1038/sj.leu.2404801"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-05-03", 
    "datePublishedReg": "2010-05-03", 
    "description": "Lenalidomide is an active treatment for multiple myeloma (MM) and is increasingly used as part of the initial treatment of this disease. Recent reports have suggested decreases in the number of CD34+ cells collected and increases in the failure rate among patients whose initial therapy contained lenalidomide when mobilized with G-CSF alone. A retrospective data analysis of 364 patients with MM who underwent stem cell mobilization and attempted harvest at the Hospital of the University of Pennsylvania between January 2002 and December 2007 was performed. Forty-three of the patients received lenalidomide in their induction regimen, and were mobilized with either CY and G-CSF or G-CSF alone. The number of apheresis cycles and the failure rate were lower, whereas the mean number of collected stem cells was higher in patients who were mobilized with CY and G-CSF in comparison with G-CSF alone. This suggests that lenalidomide does not prevent the harvest of adequate numbers of CD34 cells for autologous stem cell transplant, but mobilization with G-CSF and CY may be required to obtain adequate numbers of stem cells. Finally, in our study, the number of lenalidomide cycles did not correlate with stem cell yield.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bmt.2010.63", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "46"
      }
    ], 
    "keywords": [
      "multiple myeloma", 
      "autologous stem cell transplant", 
      "collected stem cells", 
      "stem cell transplant", 
      "number of CD34", 
      "stem cell mobilization", 
      "retrospective data analysis", 
      "stem cell yield", 
      "stem cells", 
      "apheresis cycles", 
      "lenalidomide cycles", 
      "initial therapy", 
      "induction regimen", 
      "induction therapy", 
      "initial treatment", 
      "active treatment", 
      "cell transplant", 
      "mobilization regimen", 
      "failure rate", 
      "cell mobilization", 
      "adequate number", 
      "patients", 
      "CD34 cells", 
      "lenalidomide", 
      "cell collection", 
      "CSF", 
      "mean number", 
      "regimen", 
      "myeloma", 
      "therapy", 
      "recent reports", 
      "University of Pennsylvania", 
      "treatment", 
      "cells", 
      "transplant", 
      "cell yield", 
      "hospital", 
      "CD34", 
      "mobilization", 
      "disease", 
      "report", 
      "rate", 
      "Cys", 
      "number", 
      "decrease", 
      "data analysis", 
      "study", 
      "increase", 
      "cycle", 
      "Pennsylvania", 
      "impact", 
      "comparison", 
      "analysis", 
      "collection", 
      "part", 
      "University", 
      "harvest", 
      "yield"
    ], 
    "name": "Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen", 
    "pagination": "59-63", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041512897"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2010.63"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20421869"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2010.63", 
      "https://app.dimensions.ai/details/publication/pub.1041512897"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_504.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bmt.2010.63"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.63'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.63'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.63'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.63'


 

This table displays all metadata directly associated to this object as RDF triples.

282 TRIPLES      22 PREDICATES      104 URIs      94 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2010.63 schema:about N0907636130d04df294d722b37596be01
2 N109763578d804062b4fed27f03d310db
3 N11443c2d013049edba552254e7665ee8
4 N1d25b4b231a445d29492f6e386f3974b
5 N22b1dfae971242dba761aa83eee54ae8
6 N381b7b6af58d4fabb1862165a22ebb0c
7 N3900b2d63b5b4935a66a7db0c9a59f3a
8 N409c374334314d559927dea0ccb0aca6
9 N65dff391c80643c8b5734a8b65045ad0
10 N7a0857c09e50478d837e69db2d556827
11 Naab9e09239da4832a8b4d580e5c314d8
12 Nadd463816cac45d693d93eb4fba7cc68
13 Nbf20e43926dc46488d161397eb707440
14 Nc1b82f45d4e3490697b92c91bc0ba7c4
15 Nc9c250900b8c487cb3847683660da1df
16 Ne78dbe2896e3445399b50a70f270fa23
17 Ne854fcbd2bc44bc5970c3f3b349137ea
18 Nf799cb5100bb4be4bd4ea0b767f0f503
19 anzsrc-for:11
20 anzsrc-for:1102
21 schema:author N8548ec5b79504e86b981a26b61a01dd2
22 schema:citation sg:pub.10.1038/sj.leu.2404801
23 sg:pub.10.1038/sj.leu.2405035
24 schema:datePublished 2010-05-03
25 schema:datePublishedReg 2010-05-03
26 schema:description Lenalidomide is an active treatment for multiple myeloma (MM) and is increasingly used as part of the initial treatment of this disease. Recent reports have suggested decreases in the number of CD34+ cells collected and increases in the failure rate among patients whose initial therapy contained lenalidomide when mobilized with G-CSF alone. A retrospective data analysis of 364 patients with MM who underwent stem cell mobilization and attempted harvest at the Hospital of the University of Pennsylvania between January 2002 and December 2007 was performed. Forty-three of the patients received lenalidomide in their induction regimen, and were mobilized with either CY and G-CSF or G-CSF alone. The number of apheresis cycles and the failure rate were lower, whereas the mean number of collected stem cells was higher in patients who were mobilized with CY and G-CSF in comparison with G-CSF alone. This suggests that lenalidomide does not prevent the harvest of adequate numbers of CD34 cells for autologous stem cell transplant, but mobilization with G-CSF and CY may be required to obtain adequate numbers of stem cells. Finally, in our study, the number of lenalidomide cycles did not correlate with stem cell yield.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N8e00b66c446648e89888949f1c5c9885
31 Nd8b75bdc27864928a0daa4c2e6d6bbde
32 sg:journal.1096890
33 schema:keywords CD34
34 CD34 cells
35 CSF
36 Cys
37 Pennsylvania
38 University
39 University of Pennsylvania
40 active treatment
41 adequate number
42 analysis
43 apheresis cycles
44 autologous stem cell transplant
45 cell collection
46 cell mobilization
47 cell transplant
48 cell yield
49 cells
50 collected stem cells
51 collection
52 comparison
53 cycle
54 data analysis
55 decrease
56 disease
57 failure rate
58 harvest
59 hospital
60 impact
61 increase
62 induction regimen
63 induction therapy
64 initial therapy
65 initial treatment
66 lenalidomide
67 lenalidomide cycles
68 mean number
69 mobilization
70 mobilization regimen
71 multiple myeloma
72 myeloma
73 number
74 number of CD34
75 part
76 patients
77 rate
78 recent reports
79 regimen
80 report
81 retrospective data analysis
82 stem cell mobilization
83 stem cell transplant
84 stem cell yield
85 stem cells
86 study
87 therapy
88 transplant
89 treatment
90 yield
91 schema:name Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen
92 schema:pagination 59-63
93 schema:productId N303b0439470a4d02acf47e7e4025de6d
94 N7acdba7e85564007935fc53e5cbea51a
95 Na5733f4af2834d24bd879b7e78ca5a2c
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041512897
97 https://doi.org/10.1038/bmt.2010.63
98 schema:sdDatePublished 2022-01-01T18:21
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher Nbadcf7dd348d40dfae641b1ca61f7c2b
101 schema:url https://doi.org/10.1038/bmt.2010.63
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N0907636130d04df294d722b37596be01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Medical Records
107 rdf:type schema:DefinedTerm
108 N109763578d804062b4fed27f03d310db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Thalidomide
110 rdf:type schema:DefinedTerm
111 N11443c2d013049edba552254e7665ee8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Drug Therapy, Combination
113 rdf:type schema:DefinedTerm
114 N116bea8be54e46c0b1215df28f54c60f schema:affiliation grid-institutes:grid.25879.31
115 schema:familyName Gardler
116 schema:givenName M
117 rdf:type schema:Person
118 N1d25b4b231a445d29492f6e386f3974b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Lenalidomide
120 rdf:type schema:DefinedTerm
121 N1e7935f0aeb64d5f99f681b666715e60 rdf:first sg:person.014314214442.02
122 rdf:rest N86dce65cac1d4db3920de8515ccc08aa
123 N2141b4ab7b15401d8a6493f090fbbceb rdf:first sg:person.0626647504.50
124 rdf:rest N1e7935f0aeb64d5f99f681b666715e60
125 N22b1dfae971242dba761aa83eee54ae8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cyclophosphamide
127 rdf:type schema:DefinedTerm
128 N303b0439470a4d02acf47e7e4025de6d schema:name pubmed_id
129 schema:value 20421869
130 rdf:type schema:PropertyValue
131 N381b7b6af58d4fabb1862165a22ebb0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Transplantation Conditioning
133 rdf:type schema:DefinedTerm
134 N3900b2d63b5b4935a66a7db0c9a59f3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N409c374334314d559927dea0ccb0aca6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Antineoplastic Agents
139 rdf:type schema:DefinedTerm
140 N42e33864c320460c9bf1c8b9446cc401 rdf:first sg:person.011060364477.44
141 rdf:rest N2141b4ab7b15401d8a6493f090fbbceb
142 N44f9587b23e143eab4a0963d5185e168 rdf:first sg:person.0707416147.15
143 rdf:rest N42e33864c320460c9bf1c8b9446cc401
144 N4a703f0fece14be2aca57c0c71b00ab6 rdf:first sg:person.01342007330.30
145 rdf:rest Nf6207f92e1624b6d98a48b28885a5904
146 N4e713d7c9cbb4bb6afe1c7bf2a1032d3 rdf:first sg:person.0634210376.05
147 rdf:rest Nd9888740b8e24f83aba6da48bbc8896c
148 N52648f2b289b47c5a135a420b7fde9fc rdf:first sg:person.01175252676.87
149 rdf:rest Nf1ff2a20664f4068909e427f2665e555
150 N65dff391c80643c8b5734a8b65045ad0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Remission Induction
152 rdf:type schema:DefinedTerm
153 N79c0e03d305a41b895b3b03470046e3d schema:affiliation grid-institutes:grid.25879.31
154 schema:familyName Nazha
155 schema:givenName A
156 rdf:type schema:Person
157 N7a0857c09e50478d837e69db2d556827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Transplantation, Autologous
159 rdf:type schema:DefinedTerm
160 N7acdba7e85564007935fc53e5cbea51a schema:name doi
161 schema:value 10.1038/bmt.2010.63
162 rdf:type schema:PropertyValue
163 N82178c65a6ab4258afadaeb9095b139b rdf:first sg:person.0726540325.99
164 rdf:rest N4e713d7c9cbb4bb6afe1c7bf2a1032d3
165 N8548ec5b79504e86b981a26b61a01dd2 rdf:first N79c0e03d305a41b895b3b03470046e3d
166 rdf:rest N52648f2b289b47c5a135a420b7fde9fc
167 N86dce65cac1d4db3920de8515ccc08aa rdf:first sg:person.01044042041.97
168 rdf:rest rdf:nil
169 N8e00b66c446648e89888949f1c5c9885 schema:issueNumber 1
170 rdf:type schema:PublicationIssue
171 Na5733f4af2834d24bd879b7e78ca5a2c schema:name dimensions_id
172 schema:value pub.1041512897
173 rdf:type schema:PropertyValue
174 Naab9e09239da4832a8b4d580e5c314d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Treatment Outcome
176 rdf:type schema:DefinedTerm
177 Nadd463816cac45d693d93eb4fba7cc68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Granulocyte Colony-Stimulating Factor
179 rdf:type schema:DefinedTerm
180 Nbadcf7dd348d40dfae641b1ca61f7c2b schema:name Springer Nature - SN SciGraph project
181 rdf:type schema:Organization
182 Nbf20e43926dc46488d161397eb707440 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Multiple Myeloma
184 rdf:type schema:DefinedTerm
185 Nc1b82f45d4e3490697b92c91bc0ba7c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Peripheral Blood Stem Cell Transplantation
187 rdf:type schema:DefinedTerm
188 Nc9c250900b8c487cb3847683660da1df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Blood Component Removal
190 rdf:type schema:DefinedTerm
191 Nd8b75bdc27864928a0daa4c2e6d6bbde schema:volumeNumber 46
192 rdf:type schema:PublicationVolume
193 Nd9888740b8e24f83aba6da48bbc8896c rdf:first sg:person.012415664717.68
194 rdf:rest N44f9587b23e143eab4a0963d5185e168
195 Ne78dbe2896e3445399b50a70f270fa23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Antigens, CD34
197 rdf:type schema:DefinedTerm
198 Ne854fcbd2bc44bc5970c3f3b349137ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Hematopoietic Stem Cell Mobilization
200 rdf:type schema:DefinedTerm
201 Nf1ff2a20664f4068909e427f2665e555 rdf:first sg:person.01154427341.76
202 rdf:rest N4a703f0fece14be2aca57c0c71b00ab6
203 Nf6207f92e1624b6d98a48b28885a5904 rdf:first N116bea8be54e46c0b1215df28f54c60f
204 rdf:rest N82178c65a6ab4258afadaeb9095b139b
205 Nf799cb5100bb4be4bd4ea0b767f0f503 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Retrospective Studies
207 rdf:type schema:DefinedTerm
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
212 schema:name Cardiorespiratory Medicine and Haematology
213 rdf:type schema:DefinedTerm
214 sg:journal.1096890 schema:issn 0268-3369
215 1476-5365
216 schema:name Bone Marrow Transplantation
217 schema:publisher Springer Nature
218 rdf:type schema:Periodical
219 sg:person.01044042041.97 schema:affiliation grid-institutes:grid.25879.31
220 schema:familyName Stadtmauer
221 schema:givenName E A
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
223 rdf:type schema:Person
224 sg:person.011060364477.44 schema:affiliation grid-institutes:grid.25879.31
225 schema:familyName Schuster
226 schema:givenName S
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44
228 rdf:type schema:Person
229 sg:person.01154427341.76 schema:affiliation grid-institutes:grid.25879.31
230 schema:familyName Vogl
231 schema:givenName D T
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154427341.76
233 rdf:type schema:Person
234 sg:person.01175252676.87 schema:affiliation grid-institutes:grid.25879.31
235 schema:familyName Cook
236 schema:givenName R
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175252676.87
238 rdf:type schema:Person
239 sg:person.012415664717.68 schema:affiliation grid-institutes:grid.25879.31
240 schema:familyName Luger
241 schema:givenName S M
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012415664717.68
243 rdf:type schema:Person
244 sg:person.01342007330.30 schema:affiliation grid-institutes:grid.25879.31
245 schema:familyName Mangan
246 schema:givenName P A
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342007330.30
248 rdf:type schema:Person
249 sg:person.014314214442.02 schema:affiliation grid-institutes:grid.25879.31
250 schema:familyName Siegel
251 schema:givenName D
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014314214442.02
253 rdf:type schema:Person
254 sg:person.0626647504.50 schema:affiliation grid-institutes:grid.25879.31
255 schema:familyName O'Doherty
256 schema:givenName U
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626647504.50
258 rdf:type schema:Person
259 sg:person.0634210376.05 schema:affiliation grid-institutes:grid.25879.31
260 schema:familyName Cunningham
261 schema:givenName K
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634210376.05
263 rdf:type schema:Person
264 sg:person.0707416147.15 schema:affiliation grid-institutes:grid.25879.31
265 schema:familyName Porter
266 schema:givenName D L
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15
268 rdf:type schema:Person
269 sg:person.0726540325.99 schema:affiliation grid-institutes:grid.25879.31
270 schema:familyName Hummel
271 schema:givenName K
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726540325.99
273 rdf:type schema:Person
274 sg:pub.10.1038/sj.leu.2404801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011029060
275 https://doi.org/10.1038/sj.leu.2404801
276 rdf:type schema:CreativeWork
277 sg:pub.10.1038/sj.leu.2405035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027346890
278 https://doi.org/10.1038/sj.leu.2405035
279 rdf:type schema:CreativeWork
280 grid-institutes:grid.25879.31 schema:alternateName Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
281 schema:name Hematologic Malignancies and Bone Marrow Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
282 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...